Trial Profile
Open-label study to assess safety and efficacy of a single dose (i.v.) of NMK36 in subjects with prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Sponsors Nihon Medi-Physics
- 01 Jun 2016 New trial record